Woman dies by suicide after heartbreaking battle with Lyme disease

A 22-year-old Canadian woman struggling with a debilitating case of Lyme disease committed suicide “to free herself from the unbearable pain,” her grieving dad said.

“It is with the heaviest of hearts (and still in shock) that I share the tragic news that our sweetheart Amelie (22) took her own life this past Sunday,” Alain Champagne, CEO of Le Groupe Maurice in Canada, wrote on LinkedIn earlier this month.

“We were witnesses as to how challenging life had become for her in dealing with the evolving Lyme disease symptoms,” the grief-stricken father continued.

He explained that his daughter had suffered for years but only recently received the diagnosis in the US in June — after “years of medical errance” in their home city of Quebec.

Amelie Champagne, 22
Amelie Champagne, 22, took her own life after struggling for years with undiagnosed Lyme disease.

He wrote that “over time and despite the recent treatments, the disease had evolved way beyond the numerous physical symptoms and was now severely impacting her brain.”

He said Amelie was so wracked by the tick-borne bacterial infection that “she decided to free herself from the unbearable pain,” Champagne wrote.

Amelie Champagne, 22
“Amelie left a long-lasting impression through her engaging and empathetic personality,” her dad, Alain, wrote on LinkedIn.

But despite his daughter’s illness, the father gushed about the impact Amelie had on those she met.

“Amelie left a long-lasting impression through her engaging and empathetic personality. Despite the struggles of the past few years she persevered through university, kept working at a respite center for handicapped kids, was starting to volunteer at a homeless shelter near our place … and remained ever the vibrant/fun-loving friend and member of our family,” he said.

Alain Champagne, whose daughter died by suicide after her battle with Lyme Disease.
Alain Champagne, CEO of Le Groupe Maurice in Canada, shared his heartbreak in a viral post.

Lyme disease, the most common vector-borne disease in the US, is caused by the bacterium Borrelia burgdorferi, and sometimes Borrelia mayonii, according to the Centers for Disease Control and Prevention.

Common symptoms include fever, headache, fatigue and a characteristic skin rash. If left untreated, infection can spread to joints, the heart, and the nervous system.

Most cases can be treated successfully with antibiotics if diagnosed. However, diagnosis can be difficult because early symptoms are common to many other illnesses.

Canadian pop-rock star Avril Lavigne also suffered a severe case of Lyme disease. Lavigne, 37, who was diagnosed in 2015, said it was so debilitating, she had “accepted death.”

“I had accepted death and could feel my body shutting down. I felt like I was drowning. Like I was going under water and I just needed to come up for air. Like I was in a river being pulled in a current. Unable to breathe,” she wrote in an open letter to fans in 2018.

The singer has launched a foundation, The Avril Lavigne Foundation, to help fight the disease.

Also Read: A vaccine for Lyme disease is in its final clinical trial

Woman dies by suicide after heartbreaking battle with Lyme disease

3 thoughts on “Woman dies by suicide after heartbreaking battle with Lyme disease

  1. This is so heartbreaking but an eye opener on how doctors leave you high and dry with mold illness it chronic Lyme. They let you die a slow horrible death until you can’t handle it anymore.

  2. The doctors and the entire medical community, Lyme is a disease that is unfortunately under the political agenda of big pharma and it’s investors . We have been fighting this for 30 years , it’s a terrible thing and people fall into despair after fighting hard to beat it , it’s a criminal offense to make people suffer like this but politics does not care about anything but winning . I am so sorry for the people and families that are enduring loosing everything to this unfortunate and terrible disease.

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to top